Featured Stories

At Boston Scientific, we are working to confront climate change with a goal of achieving net-zero GHG emissions by 2050. In 2024, we made noteworthy progress by achieving 100% renewable electricity.

Benign prostatic hyperplasia (BPH) is a rapidly growing urological concern driven by a global aging population. With healthcare systems under strain due to increased demand, resource limitations,...

This year, TheraSphere™ Y-90 Glass Microspheres celebrates its 20th anniversary. Since its launch, TheraSphere has changed the way liver cancers are treated, helping more than 100,000 patients worldwide and over 30, 000 patients in the EMEA region.

Percutaneous cryoablation, a minimally invasive treatment which targets cancer cells with extreme cold via a needle, was as effective at treating a type of kidney cancer as removing tumours via a...

Across the healthcare sector, organisations are reassessing their environmental impact and seeking ways to reduce it. Boston Scientific believes that advancing science for life goes hand in hand...